Correction to: Micro RNA -16 inhibits glioma cell growth and invasion through suppression of BCL 2 and the nuclear factor-κB1/ MMP 9 signaling pathway (Cancer Science, (2014), 105, 3, (265-271), 10.1111/cas.12351);MicroRNA-16 inhibits glioma cell growth and invasion through suppression of BCL2 and the nuclear factor-κB1/MMP9 signaling pathway

Cancer Science

Volumn 105, Issue 3, 2014, Pages 265-271

  Yang, Tian Quan ^a   Lu, Xiao Jun ^b   Wu, Ting Feng ^a   Ding, Da Dong ^a   Zhao, Zhao Hui ^a   Chen, Gui Lin ^a   Xie, Xue Shun ^a   Li, Bin ^a   Wei, Yong Xin ^a   Guo, Ling Chuan ^a   Zhang, Yu ^b   Huang, Yu Lun ^a   Zhou, You Xin ^a   Du, Zi Wei ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b First People's Hospital of Taicang   (China)

Author keywords

BCL2; Glioma; MiR 16; MMP9; NF B1

Indexed keywords

GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA 16; NUCLEAR FACTOR KAPPA B 1; OLIGONUCLEOTIDE; PROTEIN BCL 2; UNCLASSIFIED DRUG;

APOPTOSIS ASSAY; ARTICLE; BRAIN TISSUE; CANCER GROWTH; CARCINOGENESIS; CELL GROWTH; CELL INVASION; CELL MIGRATION; CORRELATION ANALYSIS; DOWN REGULATION; GLIOMA CELL; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LUCIFERASE ASSAY; MOUSE MODEL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR INVASION; UPREGULATION; WESTERN BLOTTING;

BCL2; GLIOMA; MIR-16; MMP9; NF-ΚB1;

ANIMALS; APOPTOSIS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, NUDE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; NF-KAPPA B P50 SUBUNIT; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR BURDEN;

EID: 84895529094     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.15343     Document Type: Erratum

References (37)

1. Taylor LP. Diagnosis, treatment, and prognosis of glioma: five new things. Neurology 2010; 75: S28-32.
2. He L, He X, Lowe SW, Hannon GJ. microRNAs join the p53 network-another piece in the tumour-suppression puzzle. Nat Rev Cancer 2007; 7: 819-22.
3. Kent OA, Mendell JT. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene 2006; 25: 6188-96.
4. Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007; 449: 682-8.
5. Mayr C, Hemann MT, Bartel DP. Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 2007; 315: 1576-9.
6. Calin GA, Dumitru CD, Shimizu M et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002; 99: 15524-9.
7. Xia L, Zhang D, Du R et al. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int J Cancer 2008; 123: 372-9.
8. Cimmino A, Calin GA, Fabbri M et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 2005; 102: 13944-9.
9. Guo CJ, Pan Q, Li DG, Sun H, Liu BW. miR-15b and miR-16 are implicated in activation of the rathepatic stellate cell: An essential role for apoptosis. J Hepatol 2009; 50: 766-78.
10. Tektonidis M, Hatzikirou H, Chauvière A, Simon M, Schaller K, Deutsch A. Identification of intrinsic in vitro cellular mechanisms for glioma invasion. J Theor Biol 2011; 287: 131-47.
11. Goldbrunner RH, Bernstein JJ, Tonn JC. Cell-extracellular matrix interaction in glioma invasion. Acta Neurochir (Wien) 1999; 141: 295-305.
12. Bikfalvi A, Moenner M, Javerzat S, North S, Hagedorn M. Inhibition of angiogenesis and the angiogenesis/invasion shift. Biochem Soc Trans 2011; 39: 1560-4.
13. Jiang L, Lin C, Song L et al. MicroRNA-30e* promotes human glioma cell invasiveness in an orthotopic xenotransplantation model by disrupting the NF-kappaB/IkappaBalpha negative feedback loop. J Clin Invest 2012; 122: 33-47.
14. Li J, Gong LY, Song LB et al. Oncoprotein Bmi-1 renders apoptotic resistance to glioma cells through activation of the IKK-nuclear factor-kappaB Pathway. Am JPathol 2010; 176: 699-709.
15. Hayashi S, Yamamoto M, Ueno Y et al. Expression of nuclear factor-kappa B, tumor necrosis factor receptor type 1, and c-Myc in human astrocytomas. Neurol Med Chir (Tokyo) 2001; 41: 187-95.
16. Naugler WE, Karin M. NF-kappaB and cancer-identifying targets and mechanisms. Curr Opin Genet Dev 2008; 18: 19-26.
17. Nakada M, Nakada S, Demuth T, Tran NL, Hoelzinger DB, Berens ME. Molecular targets of glioma invasion. Cell Mol Life Sci 2007; 64: 458-78.
18. Mentlein R, Forstreuter F, Mehdorn HM, Held-Feindt J. Functional significance of vascular endothelial growth factor receptor expression on human glioma cells. J Neurooncol 2004; 67: 9-18.
19. Mantovani A. Molecular pathways linking inflammation and cancer. Curr Mol Med 2010; 10: 369-73.
20. Wu JT, Kral JG. NF-kappaB/IkappaB signaling system: a molecular target in breast cancer therapy. J Surg Res 2005; 123: 158-69.
21. Rao JS. Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer 2003; 3: 489-501.
22. Forsyth PA, Wong H, Laing TD et al. Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas. Br J Cancer 1999; 79: 1828-35.
23. Rodriguez-Pereira C, Suarez-Peñaranda JM, Barros F, Sobrido MJ, Vazquez-Salvado M, Forteza J. Analysis of 2 antiapoptotic factors in gliomas: bcl-2 overexpression and p53 mutations. Arch Pathol Lab Med 2001; 125: 218-23.
24. Alderson LM, Castleberg RL, Harsh GR 4th, Louis DN, Henson JW. Human gliomas with wild-type p53 express bcl-2. Cancer Res 1995; 55: 999-1001.
25. Reifenberger G, Collins VP. Pathology and molecular genetics of astrocytic gliomas. J Mol Med (Berl) 2004; 82: 656-70.
26. Croce CM, Calin GA. miRNAs, cancer, and stem cell division. Cell 2005; 122: 6-7.
27. Calin GA, Croce CM. MicroRNA-cancer connection: the beginning of a new tale. Cancer Res 2006; 66: 7390-4.
28. Dong JT, Boyd JC, Frierson HF Jr. Loss of heterozy-gosity at 13q14 and 13q21 in high grade, high stage prostate cancer. Prostate 2001; 49: 166-71.
29. Bieche I, Lidereau R. Loss of heterozygosity at 13q14 correlates with RB1 gene underexpression in human breast cancer. Mol Carcinog 2000; 29: 151-8.
30. Bandi N, Zbinden S, Gugger M et al. miR-15a and miR-16Are Implicated in Cell Cycle Regulation in a Rb-Dependent Manner and Are Frequently Deleted or Down-regulated in Non-Small Cell Lung Cancer. Cancer Res 2009; 69: 5553-9.
31. Hussein MR, El-Ghorori RM, El-Rahman YG. Alterations of p53, BCL-2, and hMSH2 protein expression in the normal brain tissues, gliosis, and gliomas. Int J Exp Pathol 2006; 87: 297-306.
32. Wild-Bode C, Weller M, Wick W. Molecular determinants of glioma cell migration and invasion. J Neurosurg 2001; 94: 978-84.
33. Kunishio K, Okada M, Matsumoto Y, Nagao S. Matrix metalloproteinase- 2 and -9 expression in astrocytic tumors. Brain Tumor Pathol 2003; 20: 39-45.
34. Björklund M, Koivunen E. Gelatinase-mediated migration and invasion of cancer cells. Biochim Biophys Acta 2005; 1755: 37-69.
35. Kondraganti S, Mohanam S, Chintala SK et al. Selective suppression of matrix metallop roteinase-9 in h u man glioblastoma cells by antisense gene transfer impairs glioblastoma cell invasion. Cancer Res 2000; 60: 6851-5.
36. Sato H, Seiki M. Regulatory mechanism of 92-kDa type IV collagenase gene expression which is associtated with invasiveness of tumor cells. Oncogene 1993; 8: 395-405.
37. Shin VY, Jin H, Ng EK et al. NF-κB targets miR-16 and miR-21 in gastric cancer: involvement of prostaglandin E receptors. Carcinogenesis 2011; 32: 240-5.